This combination of CT26-LMP1 tumor cell-intrinsic expression and tumor cell-extrinsic expression from infiltrating myeloid cells, particularly mDCs, is reminiscent of the mixed expression in the NPC xenografts. The gene discussed is DDX53; the disease is neoplasm.